NorthWest Biotherapeutics Inc (NWBO)

[longfellow95]

It's a mistake to think that NWBO must do things in the time-honored and expected order.
There is no single imperative to release topline at the earliest opportunity.
Nor must it then be followed up with a splash in a 'topline' journal.

Having approved manufacturing in place before regulatory application for marketing/approval, is more important than releasing topline.

Some might assert that the non-appearance (to date) of topline presages disappointing data, or a resort to trawling around for something good in subgroup data.
An assertion that I would definitely disagree with.

If one thinks that there is an intention to knock out the shorts (if indeed they exist) in one fell blow, then I would prefer to see it as a process of slow surreptitious throttling.